Nanalyze, 700 Canal Street, Stamford, CT (2025)

01/23/2025

MongoDB stock has underperformed over the years since we last covered it. And that's a good thing. Valuations have plummeted, so is it a buy?

01/17/2025

Oxford Nanopore stock is off to a hot start in 2025 based on its 2024 performance. Can it maintain momentum and be a big genomics winner?

01/14/2025

Nutanix stock is reasonably valued for a company seeing double-digit growth on the back of cloud computing growth. Can the growth continue?

01/07/2025

The cancer blood test opportunity is massive - from early detection to late-stage treatment plans, a number of stocks try to capture the alpha.

The cancer blood test opportunity is massive - from early detection to late-stage treatment plans, a number of stocks try to capture the alpha

12/31/2024

TeamViewer stock is hitting all time lows on the news they're acquiring 1E. We dig into that and decide if TeamViewer stock is one we're exiting.

TeamViewer stock is hitting all time lows on the news they're acquiring 1E. We dig into that and decide if TeamViewer stock is one we're exiting

12/29/2024

Xometry stock is ending a couple of years of volatility following a damaging short report on an upward trend. Is the optimism justified?

12/16/2024

Illumina has a new CEO and a plan. But the plan isn't compelling and expected growth is mediocre if it happens. Time to sell Illumina stock?

12/15/2024

Samsara stock is again trading at a premium despite slowing growth and lingering dependence on connected vehicles. Is it still a buy?

12/14/2024

Trulieve stock dropped like a rock after Florida voter rejected legalization of recreational cannabis. Where does the company go from here?

12/06/2024

BILL stock was one of the hottest tech stocks on the market until macroeconomic headwinds started blowing. What's next for BILL stock?

12/03/2024

Adyen expects upwards of 20% revenue growth over the next several years. They also expect to become more profitable. At least that's the plan.

Adyen expects upwards of 20% revenue growth over the next several years. They also expect to become more profitable. At least that's the plan

12/02/2024

What happened to the golden age of green technology? Solar stocks have performed poorly. Will it only get worse or is it time to buy?

11/25/2024

Natera stock has been on an absolute tear this year as the company makes significant progress in the hybrid liquid biopsy market.

11/24/2024

Teradyne stock represents a niche investment in the semiconductor sector. Will AI help increase the addressable market and revenue growth?

11/23/2024

There are many ways to invest in exciting startups, but the best approach is to do so alongside experienced venture capitalists. Here's how.

11/22/2024

Zoom stock is no longer on the fast track to $1,500 a share, but can the pandemic darling at least get revenue growth back on track?

11/21/2024

NextEra Energy $NEE has nuclear exposure and is seeing strong demand from AI data centers. We look through the hype to see what's happening.

11/20/2024

Intapp stock got a big bump after the company's excellent 2024 earnings call. Can the AI fintech continue the momentum beyond the hype cycle?

Nanalyze